COMBINATION OF HEDYOTIS CORYMBOSA L. AND TINOSPORA CRISPA ETHANOLIC EXTRACT INCREASE CISPLATIN CYTOTOXICITY ON T47D BREAST CANCER CELLS

Rollando Rollando

doi:10.22159/ajpcr.2018.v11i7.25607

Authors

Rollando Rollando Program of Pharmacy, Faculty of Science and Technology, Ma Chung University, Malang, East Java, Indonesia. http://orcid.org/0000-0001-6210-6247

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i7.25607

Keywords:

Cisplatin, Cytotoxicity, Hedyotis corymbosa L, Tinospora crispa

Abstract

Objective: Ursolic acid was a compound found in Hedyotis corymbosa L., (HCoL) while berberine found in Tinospora crispa (TCa) which are proven to have cytotoxic effect to cancer cells. This research aims to review the effect of cisplatin, ethanolic extract of HCoL and TCa to the sensitivity increase on breast cancer cells, which will be confirmed through apoptosis induction and cell cycle modulation.

Methods: The cytotoxic effect was tested using 3-(4,5-dimethylthiazol-2-il)-2,5-diphenyltetrazolium bromide assay on T47D cell using the IC50 parameter. The combination was tested by determining their combination index (CI) and cell viability. The combination effect of apoptosis induction and cell cycle modulation was observed using flow cytometry method.

Results: The cytotoxic test result of the combination shows CI value of below 1 at the concentration of HCoL ethanolic extract as much as 1 Î¼g/mL, TCa ethanolic extract as much as 6 Î¼g/mL, and cisplatin as much as 2,5 Î¼M. The combination of HCoL ethanolic extract, TCa ethanolic extract, and cisplatin results in phase S cell accumulation (29.98%) on breast cancer cell T47D and was able to induce apoptosis.

Conclusion: The result proves that ethanolic extract of HCoL and TCa can be developed as a cochemotherapeutic agent with cisplatin to increase the effectivity of breast cancer treatment.

Downloads

Download data is not yet available.

Author Biography

Rollando Rollando, Program of Pharmacy, Faculty of Science and Technology, Ma Chung University, Malang, East Java, Indonesia.

Program of Pharmacy, Faculty of Science and Technology, Ma Chung University, 65151 Malang, Indonesia

References

Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): A population-based study. Lancet Oncol 2012;13:790-801.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:359-86.

Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E. Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23:11-9.

Valeriote F, Grieshaber CK, Media J, Pietraszkewicz H, Hoffmann J, Pan M, et al. Discovery and development of anticancer agents from plants. J Exp Ther Oncol 2002;2:228-36.

Rebucci M, Michiels C. Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol 2013;85:1219-26.

Minami M, Matsumoto S, Horiuchi H. Cardiovascular side-effects of modern cancer therapy. Circ J Off J Japanese Circ Soc 2010;74:1779-86.

Incorvati JA, Shah S, Mu Y, Lu J. Targeted therapy for early HER2 positive breast cancer. J Hematol Oncol 2013;6:1-9.

Jerusalem G, Rorive A, Collignon J. Use of mTOR inhibitors in the treatment of breast cancer: An evaluation of factors that influence patient outcomes. Breast Cancer Targets Ther 2014;6:43-57.

Noviyani R, Indrayathi PA, Budiana IN, Suwiyoga K, Tunas K. Assessment of life quality in patiens with stage IIB-IIIB squamous cell cervical cancer receiving paclitaxel cisplatin chemotherapy regiment by EORTC QLQ-C30 questionnaire in sanglah hospital denpasar. Int J Pharm Pharm Sci 2017;9:22-6.

Gautam RK, Singh RK, Ms K. Evaluation of nephroprotective activity of menthe arvensis in cisplatin induced nephrotoxicity. Asian J Pharm Clin Res 2014;7:188-91.

Florea AM, BÃ¼sselberg D. Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects. Cancers 2011;3:1351-71.

Al-zubaidy AA, Sahib HB, Hussein ZA. The anti-angiogenic activity of Phoenix dactylifera seeds extracts. Int J Pharm Pharm Sci 2015;8:311-5.

Pitaloka DA, Sukandar EY. In vitro study of ursolic acid combination first-line antituberculosis drugs against drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis. Asian J Pharm Clin Res 2017;10:216-8.

Choudhary MI, Ismail M, Shaari K, Abbaskhan A, Sattar SA, Lajis NH, et al. Cis-clerodane-type furanoditerpenoids from Tinospora crispa. J Nat Prod 2010;73:541-7.

Zhao L, Wientjes MG, Au JL. Evaluation of combination chemotherapy: Integration of nonlinear regression, curve shift, isobologram, and combination index analyses. Clin Cancer Res 2004;10:7994-8004.

Schafer JM, Lee ES, Oâ€™Regan RM, Yao K, Jordan VC. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice. Clin Cancer Res 2000;6:4373-80.

Mokhtari MJ, Akbarzadeh A, Hashemi M. cisplatin induces down regulation of BCL2 in T47D breast cancer cell line. Adv Stud Biol 2012;4:19-25.

Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 1999;99:2467-98.

Falck J, Petrini JH, Williams BR, Lukas J, Bartek J. The DNA damage dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Genet 2002;30:290-4.

Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, Bartek J. Rapid destruction of Cdc25A in response to DNA damage. Science 2002;88:1425-9.

Costanzo V, Robertson K, Ying CY, Kim E, Avvedoimento E, Gottesman M. Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage. Mol Cell 2000;6:649-59.

Yuniati Y, Rollando R. Isolation of antibacterial compounds from endophyte fungal of Fusarium sp. In Phyllanthus niruri linn. Leaves. J Pharm Sci Res 2018;10:260-4.

Rollando R. Hedyotis corymbosa L. and Sterculia quadrifida R.Br ethanolic extract enhances cisplatinâ€™s cytotoxicity on T47D breast cancer cells through cell cycle modulation. J Pure Appl Chem Res 2018;7:63-75.

Kim GY, Mercer SE, Ewton DZ, Yan Z, Jin K, Friedman E. The stress-activated protein kinases p38 alpha and JNK1 Stabilize p21(Cip1) BY phosphorylation. J Biol Chem 2002;277:29792-802.

Goloudina A, Yamaguchi H, Chervyakova, DB, Appella E, Fornace AJ, Bulavin DV. Regulation of human Cdc25A stability by serine 75 phosphorylation is not sufficient to activate a s phase checkpoint. Cell Cycle 2003;2:269-73.